Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
TEB-17231 by 280Bio for Solid Tumor: Likelihood of Approval
TEB-17231 is under clinical development by 280Bio and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...